Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Keratoconjunctivitis
MeSH D007637 - keratoconjunctivitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D003231:
Conjunctivitis
67 Companies
14 Drugs
$
Success rate
D007634:
Keratitis
63 Companies
16 Drugs
$
Success rate
D007637:
Keratoconjunctivitis
1 Company
1 Drug
$
Success rate
D007638:
Keratoconjunctivitis sicca
0 Companies
0 Drugs
Success rate
D007639:
Infectious keratoconjunctivitis
7 Companies
3 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/1
Phase 2
0
%
0/2
Phase 3
33
%
1/3
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novartis
Rebamipide
,
Antacid
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use